Member Info for Zoom0001

No one’s said it’s huge good news. Rather a good housekeeping exercise. Upfront payment & reduced negative cash outflow. You seem upset by this..

https://www.londonstockexchange.com/news-article/AVCT/vimian-acquires-avactaas-animal-health-division/15369729

Anyone who seeks reassurance form Myles or Ophidians position’s frankly needs their head checking.

Afternoon Goose. I can’t see where they’ve said they will publish the initial data by the end of 2021. He said “we should know”. I can only assume he is talking about those involved with the trials rather than the broader audience. Happy to be corrected though. I guess the initial data was encouraging enough to escalate the dose.

I’ll give it a swerve for a while as some of the chief rampers have returned. It is however worth having a listen to the video in this tweet courtesy of tomthebomb. We’ve seen it before but it’s a good reminder.

https://mobile.twitter.com/tom_the_bomb__/status/1503714051922268170

https://www.londonstockexchange.com/news-article/AEG/active-energy-receives-fsc-r-certification/15367751

Like the sound of this.

With its strong balance sheet, the Group expects to deliver major value inflection points from its well-funded therapeutic programmes over the next 12 months and deliver near to medium term revenues from its diagnostic business, driving long-term shareholder value.

All the best Poirot. Hope everything works out.

Genuinely hope it gets back there & you make some profit.

Thoroughly deserved. What a difference a couple of days can make!

ABDX never deserved to be sub 8p. It was always going to correct itself.

Don’t disagree with you at this stage Blackcat as in there’s not too much to be exited about, however we have an entire diagnostics division hopefully working on something & I’ve read that the LFT market (not just covid) will be around 13 billion by 2026 in more than one publication. Agree about omicron being mild etc but there’s no guarantee the next mutation will be the same if there is one.

Certainly not pinning my hopes on Affidx but imagine there will be opportunities to exploit for DX in general.

Mentioned this last week. Rising BA.2/BA.3, plus Deltacron now confirmed as a variant. Also suggestion that Europe may be at the beginning of a 5th wave.

I notice their websites up & running again. No mention of Meduflow but it’s encouraging that they haven’t turned the lights off.

https://shop.medusa19.com/en_GB/taxons/covid19-tests?channel_type=business

Welcome back. Share price going up & you’re still a twat. Just like the good old days.

Let’s see what happens Agentb. Our test was working better than most until Omicron. I still don’t believe that the approved tests are/were much better than ours. My personal experience suggests they don’t work well at all.

Looks like they failed to submit inline with updated regulation. Shambolic doesn’t even begin to describe them.

Whilst the perception is that covid is no longer a thing. BA.2 looks like it’s going to be problematic.

https://www.dailymail.co.uk/news/article-10599205/Daily-Covid-admissions-rise-7TH-day-row-cases-jump-56-week.html

Sure do. They were the days!

*if.